Prehab Prior to Stem Cell Transplantation in Multiple Myeloma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alberta

About this trial

The primary purpose of this study is to see if individuals with Multiple Myeloma are able and interested in taking part in a tailored exercise program while undergoing their chemotherapy prior to a stem cell transplant. We also hope to learn if this type of program, along with a flexible delivery format (in-person and virtual), helps in maintaining or improving physical fitness, muscle mass and strength, and quality of life during chemotherapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Have a diagnosis of Multiple Myeloma

Be transplant eligible

Be undergoing chemotherapy prior to, or following an autologous stem cell transplant as part of their cancer treatment; or transplant ineligible.

Be an Alberta resident

Disqualifiers

Their disease status/comorbidities preclude exercise testing or participation

They are unable to commit to the 10-week exercise program and/or testing sessions at the Cancer Rehabilitation Clinic at the University of Alberta

They do not have regular access to the internet and/or an electronic device in the home.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Supported Exercise

    Behavioral

    Participants will take part in a prehabilitation exercise program prior to undergoing a stem cell transplant.

  • Standard Care

    Behavioral

    Participants will receive standard care

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Standard CareActive comparator 1 intervention
Group B: Supported Exercise GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Study completion rate

The percentage of participants who complete the study, including the intervention and follow-up assessment

Time frame
10-weeks

Secondary outcomes

1

Recruitment rate

The percentage of participants who are eligible and consent to participate in the study.

Time frame
18 months
2

Attendance rate

The percentage of group and individual exercise sessions completed over the 10 weeks.

Time frame
18 months
3

Edmonton Symptom Assessment System

Tool to assess 11 symptoms related to cancer: higher scores reflect worse symptom burden

Time frame
10 weeks
4

Functional Assessment of Cancer Therapy Multiple Myeloma

Health-related quality of life questionnaire: higher scores reflect better quality of life

Time frame
10 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.